Envoy Medical Statistics Share Statistics Envoy Medical has 21.52M
shares outstanding. The number of shares has increased by 8.81%
in one year.
Shares Outstanding 21.52M Shares Change (YoY) 8.81% Shares Change (QoQ) 0.15% Owned by Institutions (%) 10.8% Shares Floating 10.19M Failed to Deliver (FTD) Shares 394 FTD / Avg. Volume 0.15%
Short Selling Information The latest short interest is 93.61K, so 0.43% of the outstanding
shares have been sold short.
Short Interest 93.61K Short % of Shares Out 0.43% Short % of Float 0.86% Short Ratio (days to cover) 5.01
Valuation Ratios The PE ratio is -1.29 and the forward
PE ratio is -1.09.
Envoy Medical's PEG ratio is
0.03.
PE Ratio -1.29 Forward PE -1.09 PS Ratio 119.42 Forward PS 100.1 PB Ratio -1.43 P/FCF Ratio -1.42 PEG Ratio 0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Envoy Medical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.24,
with a Debt / Equity ratio of -1.04.
Current Ratio 1.24 Quick Ratio 1.02 Debt / Equity -1.04 Debt / EBITDA -0.99 Debt / FCF -1.04 Interest Coverage -23.6
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $5.36K Profits Per Employee $-495.12K Employee Count 42 Asset Turnover 0.02 Inventory Turnover 0.43
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -57.42% in the
last 52 weeks. The beta is 2.18, so Envoy Medical's
price volatility has been higher than the market average.
Beta 2.18 52-Week Price Change -57.42% 50-Day Moving Average 1.45 200-Day Moving Average 1.54 Relative Strength Index (RSI) 48.15 Average Volume (20 Days) 265,416
Income Statement In the last 12 months, Envoy Medical had revenue of 225K
and earned -20.8M
in profits. Earnings per share was -1.49.
Revenue 225K Gross Profit -517K Operating Income -19.26M Net Income -20.8M EBITDA -19.81M EBIT -19.98M Earnings Per Share (EPS) -1.49
Full Income Statement Balance Sheet The company has 5.48M in cash and 19.66M in
debt, giving a net cash position of -14.18M.
Cash & Cash Equivalents 5.48M Total Debt 19.66M Net Cash -14.18M Retained Earnings -284.73M Total Assets 9.9M Working Capital -487K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -17.95M
and capital expenditures -980K, giving a free cash flow of -18.93M.
Operating Cash Flow -17.95M Capital Expenditures -980K Free Cash Flow -18.93M FCF Per Share -1.01
Full Cash Flow Statement Margins Gross margin is -229.78%, with operating and profit margins of -8558.22% and -9242.22%.
Gross Margin -229.78% Operating Margin -8558.22% Pretax Margin -9242.22% Profit Margin -9242.22% EBITDA Margin -8802.67% EBIT Margin -8558.22% FCF Margin -8412.89%
